Skip to main content
. Author manuscript; available in PMC: 2020 Nov 19.
Published in final edited form as: Urol Oncol. 2017 Sep 23;36(1):8.e17–8.e24. doi: 10.1016/j.urolonc.2017.08.027

Table 2.

Multivariable Cox regression analyses predicting disease recurrence, and disease progression5122 patients with non-muscle invasive bladder cancer (NMIBC)

Disease recurrence Disease progression

Characteristics HR 95% CI p value HR 95% CI p value

EAU risk category
Low-risk - Referent - - Referent -
Intermediate-risk 1.86 1.59–2.17 < 0.001 3.55 1.92–6.54 < 0.001
High-risk 2.02 1.72–2.36 < 0.001 9.36 5.12–17.11 < 0.001

Analysis adjusted for age (continuous) and type of intravesical therapy (no therapy vs. immediate postoperative instillation, adjuvant intravesical chemotherapy, BCG)